Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2189470 | 0.79 | KDM4E (0.36) | TDP1KDM4EGAAMAPTKMT2A | |
| SCHEMBL8666230 | 0.79 | KDM4E (0.36) | TDP1KDM4EGAAMAPTKMT2A | |
| SCHEMBL3074210 | 0.77 | — | — | |
| SCHEMBL3074211 | 0.77 | — | — | |
| SCHEMBL11748394 | 0.73 | MMP1 (0.41) | TDP1KDM4EGAAMAPTKMT2A | |
| SCHEMBL28792604 | 0.73 | ALDH1A1 (0.39) | TDP1KDM4EGAAMAPTKMT2A | |
| SCHEMBL11748399 | 0.73 | MMP1 (0.41) | TDP1KDM4EGAAMAPTKMT2A | |
| SCHEMBL29308972 | 0.73 | ALDH1A1 (0.39) | TDP1KDM4EGAAMAPTKMT2A | |
| SCHEMBL9206174 | 0.71 | MCL1 (0.35) | TDP1KDM4EGAAMAPTKMT2A | |
| SCHEMBL2952595 | 0.71 | CYP2D6 (0.50) | GAAMAPTKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9126896-B2 | Synthesis of diamido gellants by using Dane salts of amino acids | EVONIK INDUSTRIES AG (DE) | 2015-09-08 | — | — | US | disclosed |
| US-20150073172-A1 | SYNTHESIS OF DIAMIDO GELLANTS BY USING DANE SALTS OF AMINO ACIDS | EVONIK TECHNOCHEMIE GMBH (DE) | 2015-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150073172-A1 | SYNTHESIS OF DIAMIDO GELLANTS BY USING DANE SALTS OF AMINO ACIDS | DAO, PDIA6, BCAT1 | TDP1 2297/4885KDM4E 1727/4885GAA 4206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.